SNIPR Biome - A CRISPR Company

Snipr Biome is a biotechnology and health care startup based in Denmark, founded in 2017. The company's slogan, "Clinical CRISPR and Gene Therapy of the Microbiome Company," reflects its focus on precision killing of bacteria to revolutionize the management of untreatable and difficult-to-treat infections, as well as complex diseases impacted by the human microbiota. Their mission is to develop CRISPR-based medicines that offer hope for effective and safe treatment of challenging diseases in the future. Snipr Biome recently received a $5.48M grant investment on April 22, 2024 from CARB-X, a significant milestone for the company. This investment will likely fuel their research and development efforts in clinical CRISPR and gene therapy, advancing their potential to bring groundbreaking treatments to market. As a startup specializing in cutting-edge genetic therapies and microbiome research, Snipr Biome has positioned itself at the forefront of medical innovation. Their focus on precision medicine and CRISPR-based treatments aligns with the growing demand for targeted and personalized healthcare solutions. With the support of notable investors and a compelling mission, Snipr Biome is well-positioned to make significant contributions to the future of healthcare.